DENTALCORP HOLDINGS LTD (DNTL.CA) Stock Fundamental Analysis
Canada - TSX:DNTL - CA24874B1085 - Common Stock
10.87 CAD
-0.01 (-0.09%)
DNTL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Providers & Services industry. DNTL has a medium profitability rating, but doesn't score so well on its financial health evaluation. DNTL is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DNTL was profitable.
In the past year DNTL had a positive cash flow from operations.
DNTL had negative earnings in each of the past 5 years.
DNTL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
DNTL has a Return On Assets (-1.32%) which is in line with its industry peers.
DNTL's Return On Equity of -2.55% is in line compared to the rest of the industry. DNTL outperforms 60.00% of its industry peers.
The Return On Invested Capital of DNTL (1.47%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for DNTL is significantly below the industry average of 7.83%.
The last Return On Invested Capital (1.47%) for DNTL is above the 3 year average (0.59%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.32% | ||
| ROE | -2.55% | ||
| ROIC | 1.47% |
ROA(3y)-1.62%
ROA(5y)-3.33%
ROE(3y)-3.07%
ROE(5y)-9.34%
ROIC(3y)0.59%
ROIC(5y)N/A
1.3 Margins
The Operating Margin of DNTL (4.06%) is better than 66.67% of its industry peers.
In the last couple of years the Operating Margin of DNTL has grown nicely.
DNTL's Gross Margin of 50.03% is fine compared to the rest of the industry. DNTL outperforms 80.00% of its industry peers.
In the last couple of years the Gross Margin of DNTL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.06% | ||
| PM (TTM) | N/A | ||
| GM | 50.03% |
OM growth 3YN/A
OM growth 5Y18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y-0.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DNTL is destroying value.
Compared to 1 year ago, DNTL has more shares outstanding
Compared to 5 years ago, DNTL has more shares outstanding
Compared to 1 year ago, DNTL has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.99, we must say that DNTL is in the distress zone and has some risk of bankruptcy.
DNTL has a Altman-Z score (0.99) which is in line with its industry peers.
DNTL has a debt to FCF ratio of 8.58. This is a slightly negative value and a sign of low solvency as DNTL would need 8.58 years to pay back of all of its debts.
DNTL's Debt to FCF ratio of 8.58 is fine compared to the rest of the industry. DNTL outperforms 66.67% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that DNTL is somewhat dependend on debt financing.
The Debt to Equity ratio of DNTL (0.77) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 8.58 | ||
| Altman-Z | 0.99 |
ROIC/WACC0.18
WACC8.02%
2.3 Liquidity
DNTL has a Current Ratio of 0.98. This is a bad value and indicates that DNTL is not financially healthy enough and could expect problems in meeting its short term obligations.
DNTL has a better Current ratio (0.98) than 80.00% of its industry peers.
A Quick Ratio of 0.83 indicates that DNTL may have some problems paying its short term obligations.
The Quick ratio of DNTL (0.83) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
DNTL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.86%, which is quite impressive.
DNTL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.94%.
DNTL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.02% yearly.
EPS 1Y (TTM)20.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.5%
Revenue 1Y (TTM)9.94%
Revenue growth 3Y14.44%
Revenue growth 5Y15.02%
Sales Q2Q%8.85%
3.2 Future
The Earnings Per Share is expected to grow by 10.34% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.80% on average over the next years.
EPS Next Y11.2%
EPS Next 2Y14.28%
EPS Next 3Y10.34%
EPS Next 5YN/A
Revenue Next Year10.41%
Revenue Next 2Y10.44%
Revenue Next 3Y6.19%
Revenue Next 5Y7.8%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
DNTL is valuated quite expensively with a Price/Earnings ratio of 25.88.
Based on the Price/Earnings ratio, DNTL is valued a bit cheaper than 80.00% of the companies in the same industry.
DNTL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 20.30 indicates a rather expensive valuation of DNTL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DNTL indicates a somewhat cheap valuation: DNTL is cheaper than 80.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.29. DNTL is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.88 | ||
| Fwd PE | 20.3 |
4.2 Price Multiples
DNTL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DNTL is cheaper than 80.00% of the companies in the same industry.
DNTL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DNTL is cheaper than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.84 | ||
| EV/EBITDA | 12.73 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.31
PEG (5Y)N/A
EPS Next 2Y14.28%
EPS Next 3Y10.34%
5. Dividend
5.1 Amount
DNTL has a Yearly Dividend Yield of 1.18%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.27, DNTL pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.18, DNTL pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.18% |
5.2 History
DNTL does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y14.28%
EPS Next 3Y10.34%
TSX:DNTL (10/2/2025, 7:00:00 PM)
10.87
-0.01 (-0.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners11.46%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap2.08B
Analysts83.53
Price Target12.91 (18.77%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.18% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.93%
Min EPS beat(2)-32.39%
Max EPS beat(2)-9.48%
EPS beat(4)1
Avg EPS beat(4)-23.69%
Min EPS beat(4)-69.72%
Max EPS beat(4)16.81%
EPS beat(8)4
Avg EPS beat(8)-13.63%
EPS beat(12)6
Avg EPS beat(12)-10.83%
EPS beat(16)8
Avg EPS beat(16)3.02%
Revenue beat(2)0
Avg Revenue beat(2)-1.64%
Min Revenue beat(2)-2.47%
Max Revenue beat(2)-0.81%
Revenue beat(4)1
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)0.06%
Revenue beat(8)1
Avg Revenue beat(8)-1.8%
Revenue beat(12)2
Avg Revenue beat(12)-1.39%
Revenue beat(16)3
Avg Revenue beat(16)-1.27%
PT rev (1m)0%
PT rev (3m)-0.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)57.14%
EPS NY rev (1m)-1.54%
EPS NY rev (3m)-11.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.88 | ||
| Fwd PE | 20.3 | ||
| P/S | 1.28 | ||
| P/FCF | 12.84 | ||
| P/OCF | 9.43 | ||
| P/B | 1.17 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.73 |
EPS(TTM)0.42
EY3.86%
EPS(NY)0.54
Fwd EY4.93%
FCF(TTM)0.85
FCFY7.79%
OCF(TTM)1.15
OCFY10.61%
SpS8.47
BVpS9.27
TBVpS-4.32
PEG (NY)2.31
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.32% | ||
| ROE | -2.55% | ||
| ROCE | 2.04% | ||
| ROIC | 1.47% | ||
| ROICexc | 1.51% | ||
| ROICexgc | 8.71% | ||
| OM | 4.06% | ||
| PM (TTM) | N/A | ||
| GM | 50.03% | ||
| FCFM | 9.99% |
ROA(3y)-1.62%
ROA(5y)-3.33%
ROE(3y)-3.07%
ROE(5y)-9.34%
ROIC(3y)0.59%
ROIC(5y)N/A
ROICexc(3y)0.6%
ROICexc(5y)N/A
ROICexgc(3y)3.44%
ROICexgc(5y)N/A
ROCE(3y)0.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y24.24%
ROICexc growth 3YN/A
ROICexc growth 5Y27.79%
OM growth 3YN/A
OM growth 5Y18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y-0.08%
F-Score6
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 8.58 | ||
| Debt/EBITDA | 5.1 | ||
| Cap/Depr | 29.29% | ||
| Cap/Sales | 3.62% | ||
| Interest Coverage | 0.75 | ||
| Cash Conversion | 82.84% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | 0.99 |
F-Score6
WACC8.02%
ROIC/WACC0.18
Cap/Depr(3y)18.24%
Cap/Depr(5y)15.74%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.5%
EPS Next Y11.2%
EPS Next 2Y14.28%
EPS Next 3Y10.34%
EPS Next 5YN/A
Revenue 1Y (TTM)9.94%
Revenue growth 3Y14.44%
Revenue growth 5Y15.02%
Sales Q2Q%8.85%
Revenue Next Year10.41%
Revenue Next 2Y10.44%
Revenue Next 3Y6.19%
Revenue Next 5Y7.8%
EBIT growth 1Y76.14%
EBIT growth 3YN/A
EBIT growth 5Y36.31%
EBIT Next Year85.12%
EBIT Next 3Y30.96%
EBIT Next 5Y19.8%
FCF growth 1Y69.39%
FCF growth 3Y58.7%
FCF growth 5Y157.47%
OCF growth 1Y68.86%
OCF growth 3Y52.18%
OCF growth 5Y50.41%